Investors/Forbion

4 London Mempool companies backed by Forbion

Rank =91 of 430 on the investor leaderboard. A source says it led a round in 1 of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Health44 Health companies

Portfolio on the map (4)

Verdiva Bio$411M
Clinical-stage biotech developing next-generation oral and injectable medicines for obesity and cardiometabolic disease.
Health · Obesity Therapeutics · Fastest growingLed a round
source: biospace.com
Purespring Therapeutics£115M
London gene therapy company targeting kidney podocytes to treat diseases such as IgA nephropathy.
Health · Kidney Gene Therapy · Fastest growing
source: purespringtx.com
Beacon Therapeutics
Clinical-stage gene therapy company developing treatments for retinal diseases such as X-linked retinitis pigmentosa.
Health · Ophthalmic Gene Therapy · Fastest growing
source: beacontx.com
RQ Bio
Biotech developing long-acting monoclonal antibodies to prevent seasonal flu and other respiratory viruses.
Health · Antibody Therapeutics · Fastest growing
source: uk.finance.yahoo.com

Often alongside

We list Forbion on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count